Active, Not Recruiting
A Phase 1, Dose-Escalation Trial of PT2385 Tablets In Patients With Advanced Clear Cell Renal Cell Carcinoma (MK-3795-001)
NCT02293980
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +18 more
- Locations
-
- Cedars-Sinai Medical Center Los Angeles, California, United States
- University of Colorado Cancer Center Aurora, Colorado, United States
- Yale School of Medicine New Haven, Connecticut, United States
- University of Miami - Sylvester Comprehensive Cancer Center Miami, Florida, United States